A joint session between the American Heart Association Council on Cardiovascular Surgery and Anesthesia and The Society of Thoracic Surgeons will evaluate the critical decision making that is required in managing patients with coronary artery disease. Implications of recent prospective randomized multicenter trials will be discussed.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Pavan Atluri

Elaine Tseng (Commercial Relationships: ReValve Med; Ownership interest)

Presentations

1. Key Pearls from the ISCHEMIA Trial for Surgeons - Marc Ruel

2. Hybrid Coronary Revascularization – FAD or Evidence Based? - Pavan Atluri

3. Total Arterial Revascularization – What is the Evidence? - Mario Gaudino

4. Advances in PCI – Long Term Outcomes with Modern Stents - Jay Giri

(Commercial Relationships: AstraZeneca: Consultant Advisory/Board; Boston Scientific, Research Grant; Inari Medical; Consultant Advisory/Board)

5. Beyond EXCEL: A Discussion on Subsequent Research, Findings and Reflections on Importance of CABG in Treating Left Main Disease - David Fullerton

6. Panel Discussion